Should I be taking Fosamax for osteopenia?
Doctors are rethinking as to whether or not Fosamax should be prescribed for women who have been diagnosed with osteopenia which is often but not always the precursor for osteoporosis.
Osteopenia is a condition where bone mineral density is lower than normal. It is considered by many doctors to be a precursor to osteoporosis. Yet, not everyone who is diagnosed with osteopenia will get osteoporosis.
Treatment for osteopenia should start when the fracture risk is substantial, bone density is low, or a woman already has a spine fracture.
We are an overprescribed nation. That’s what happens when television commercials repeatedly urge us to ask our doctors about the purple pill, the blue pill, the red pill, and pills, pills, pills.
One plus one does not always equal two. Some women do get osteoporosis and some don’t.
Women have been diagnosed with osteopenia in their 20s, 30s, and 40s, which is far too young to start taking Fosamax. Some women who take Fosamax for osteopenia do not see any improvement in their bone mineral density.
Should I take Fosamax for osteopenia?
There are no long-term studies that look at what happens to women with osteopenia who start Fosamax in their younger years and continue treatment long-term in the hopes of preventing old-age fractures. No studies are planned either. Women who have taken Fosamax for 5 to 10 years are experiencing femur fractures just from walking across a room.
Of course, we are not doctors and do not dispense medical advice.
You have to discuss whether or not you should take Fosamax for osteopenia with your doctor and ask about other alternatives like calcium, vitamin D, weight bearing exercises, and proper nutrition.
About Anapol Schwartz
Anapol Schwartz is nationally known for the handling of unsafe drug cases. Many pharmaceutical related injuries occur because of failures to warn of side effects, such as the case with Topamax, where clinical trials are not large enough or are too short in duration to determine increased risks. Often, the unknown effects will surface when drugs are prescribed off-label or improperly.